Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Immunogen Inc

<< Previous

Bullboard Posts

Next >>

Comment by Normandton Dec 01, 2023 11:52am

117 Views

Post# 35763563

RE:RE:RE:RE:RE:RE:RE:RE:Immunogen Inc

""Inthno, or De_man on Stocktwits is a supporter of the science, is knowledgeable and is just very frustrated with the BD side of things. He's been with the company since '99...let him vent. Good luck Norm, and good posts btw.""

Supporter of the science ??

 so why he always inserts lies here and there interspersed with truths.... No matter how frustrated we are, I don't understand his goal of always changing something in the facts to try to discourage other users. good luck you too by the way.

<< Previous

Bullboard Posts

Next >>

StockTalk | Cannabis Report: New CEO, new dispensaries, new strains